RMTG (Regenerative Medical Technology Group) Change In Receivables : $0.03 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group Change In Receivables?

Regenerative Medical Technology Group's change in receivables for the quarter that ended in Mar. 2025 was $0.01 Mil. It means Regenerative Medical Technology Group's Accounts Receivable declined by $0.01 Mil from Dec. 2024 to Mar. 2025 .

Regenerative Medical Technology Group's change in receivables for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Regenerative Medical Technology Group's Accounts Receivable declined by $0.00 Mil from Dec. 2023 to Dec. 2024 .

Regenerative Medical Technology Group's Accounts Receivable for the quarter that ended in Mar. 2025 was $0.02 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Regenerative Medical Technology Group's Days Sales Outstanding for the three months ended in Mar. 2025 was 1.07.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Regenerative Medical Technology Group's liquidation value for the three months ended in Mar. 2025 was $-30.85 Mil.

Regenerative Medical Technology Group Change In Receivables Historical Data

The historical data trend for Regenerative Medical Technology Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group Change In Receivables Chart

Regenerative Medical Technology Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-0.03

0.03

Regenerative Medical Technology Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-0.02	0.02	-0.01	0.01	0.01

Regenerative Medical Technology Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

Regenerative Medical Technology Group (OTCPK:RMTG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Regenerative Medical Technology Group's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.016	/	1.364	*	91
=	1.07

2. In Ben Graham's calculation of liquidation value, Regenerative Medical Technology Group's accounts receivable are only considered to be worth 75% of book value:

Regenerative Medical Technology Group's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.223	-	32.097	+	0.75 * 0.016	+	0.5 * 0.023
=	-30.85

Regenerative Medical Technology Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803